{"analyses":[{"ciLowerLimit":"-0.68","ciNumSides":"TWO_SIDED","ciPctValue":"95","ciUpperLimit":"0.21","dispersionType":"STANDARD_ERROR_OF_MEAN","dispersionValue":"0.228","groupIds":["OG000","OG001"],"nonInferiorityType":"SUPERIORITY","pValue":"0.3058","paramType":"LS Mean Difference (Net)","paramValue":"-0.23","statisticalMethod":"ANOVA"}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.221","value":"4.60"},{"groupId":"OG001","spread":"0.222","value":"4.37"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"754"},{"groupId":"OG001","value":"758"}],"units":"Participants"}],"description":"Number of days with supplemental oxygen use.","dispersionType":"Standard Error","groups":[{"description":"Placebo administered orally QD with standard of care.","id":"OG000","title":"Placebo + SOC"},{"description":"4 mg baricitinib administered orally QD with standard of care.","id":"OG001","title":"Baricitinib + SOC"}],"paramType":"LEAST_SQUARES_MEAN","populationDescription":"All participants randomly assigned to study intervention who have non-missing baseline and at least 1 postbaseline observation.","reportingStatus":"POSTED","timeFrame":"Day 1 to Day 28","title":"Number of Days With Supplemental Oxygen Use","type":"SECONDARY","unitOfMeasure":"days"}